Education
About Us
Working with TipRanks
Follow Us
Tilray (TLRY)
:TLRY
TLRY Stock Chart & Stats
$1.29
-$0.07(-5.17%)
At close: 4:00 PM EST
$1.29
-$0.07(-5.17%)
Day’s Range― - ―
52-Week Range$3.50 - $23.20
Previous CloseN/A
Volume22.72M
Average Volume (3M)11.35M
Market Cap
$1.29B
Enterprise Value$1.43B
Total Cash (Recent Filing)$264.83M
Total Debt (Recent Filing)$231.29M
Price to Earnings (P/E)―
Beta1.26
Next Earnings
Jan 12, 2026EPS Estimate
-0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding116,000,000
10 Day Avg. Volume24,644,109
30 Day Avg. Volume11,350,191
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.18
Price to Sales (P/S)0.34
P/FCF Ratio-2.17
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue1.23
Enterprise Value/Gross Profit4.30
Enterprise Value/Ebitda-0.48
Forecast
1Y Price Target
$7.00Price Target Upside442.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market ExpansionManagement believes the government will legalize on-premise THC beverage consumption.
Sales GrowthHigher Canadian Adult-Use And International Growth Lead To Sales.
Stock Price TargetThe price target is raised to $10 from pre-split $2.50 to take into account the stock's reverse 10-for-1 stock split.
Bears Say
Competitive PressuresCompetitive pressures are affecting the company's performance in the Canadian market.
Market ConditionsA lower 12x EV / EBITDA multiple is ascribed against the forward NTM estimate due to a challenging craft beer category backdrop.
Regulatory ChallengesTilray is dealing with permitting delays in Portugal due to the country's regulatory agency enforcing a more stringent process.
Tilray News
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was $3.50 and its highest was $23.20 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $1.29B.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jan 12, 2026 which is in 23 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Oct 09, 2025. The company reported $0 earnings per share for the quarter, beating the consensus estimate of -$0.266 by $0.266.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.21.
How many shares outstanding does Tilray have?
Tilray has 116,000,000 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of $0 in its last earnings report, beating expectations of -$0.266. Following the earnings report the stock price went up 22.093%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TLRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (442.64% Upside)
$7.00 (442.64% Upside)
Blogger Sentiment
Neutral
TLRY Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.1%
Last 30 Days ▲ 7.1%
Last 30 Days ▲ 7.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.38%
12-Months-Change
Fundamentals
Return on Equity
-85.59%
Trailing 12-Months
Asset Growth
-51.13%
Trailing 12-Months
Company Description
Tilray
Tilray, Inc. is a global leader in the cannabis industry, focused on the cultivation, production, and distribution of medical and recreational cannabis products. Founded in 2013 and headquartered in Nanaimo, British Columbia, Tilray operates across multiple sectors including pharmaceutical, consumer packaged goods, and hemp-based wellness products. The company offers a diverse range of products, including dried flower, oils, capsules, edibles, and beverages, catering to both adult-use and medical cannabis markets.
TLRY Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a balanced perspective with significant achievements in revenue growth and international expansion countered by challenges in the Beverage segment and permitting delays in Portugal.View all TLRY earnings summariesTLRY Stock 12 Month Forecast
Average Price Target
$7.00
▲(442.64% Upside)
Technical Analysis
Ownership Overview
7.27% Insiders
3.68% Mutual Funds
― Other Institutional Investors
80.69% Public Companies and Individual Investors